Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Feb;58(2):100–105. doi: 10.1136/thorax.58.2.100

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study

J Garcia-Aymerich 1, E Farrero 1, M Felez 1, J Izquierdo 1, R Marrades 1, J Anto 1
PMCID: PMC1746561  PMID: 12554887

Abstract

Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of admission to hospital among men in many countries, although the factors causing exacerbations are largely unknown. The association between readmission for a COPD exacerbation and a wide range of modifiable potential risk factors, after adjusting for sociodemographic and clinical factors, has been assessed.

Methods: Three hundred and forty patients with COPD recruited during an admission for an exacerbation in four tertiary hospitals in the Barcelona area of Spain were followed for a mean period of 1.1 years. Information on potential risk factors, including clinical and functional status, medical care and prescriptions, medication adherence, lifestyle, health status, and social support, was collected at the recruitment admission. A Cox's proportional hazards model was used to obtain independent relative risks of readmission for COPD.

Results: During the follow up period 63% of patients were readmitted at least once, and 29% died. The final multivariate model showed the following risk (or protective) factors: ⩾3 admissions for COPD in the year before recruitment (hazard ratio (HR)=1.66, 95% CI 1.16 to 2.39), forced expiratory volume in 1 second (FEV1) percentage predicted (0.97, 95% CI 0.96 to 0.99), oxygen tension (0.88, 95% CI 0.79 to 0.98), higher levels of usual physical activity (0.54, 95% CI 0.34 to 0.86), and taking anticholinergic drugs (1.81, 95% 1.11 to 2.94). Exposure to passive smoking was also related to an increased risk of readmission with COPD after adjustment for clinical factors (1.63, 95% CI 1.04 to 2.57) but did not remain in the final model.

Conclusions: This is the first study to show a strong association between usual physical activity and reduced risk of readmission to hospital with COPD, which is potentially relevant for rehabilitation and other therapeutic strategies.

Full Text

The Full Text of this article is available as a PDF (152.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ainsworth B. E., Haskell W. L., Leon A. S., Jacobs D. R., Jr, Montoye H. J., Sallis J. F., Paffenbarger R. S., Jr Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993 Jan;25(1):71–80. doi: 10.1249/00005768-199301000-00011. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
  3. Ashton C. M., Petersen N. J., Souchek J., Menke T. J., Yu H. J., Pietz K., Eigenbrodt M. L., Barbour G., Kizer K. W., Wray N. P. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999 Jan 7;340(1):32–39. doi: 10.1056/NEJM199901073400106. [DOI] [PubMed] [Google Scholar]
  4. Barberà J. A., Roca J., Ferrer A., Félez M. A., Díaz O., Roger N., Rodriguez-Roisin R. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1997 Jun;10(6):1285–1291. doi: 10.1183/09031936.97.10061285. [DOI] [PubMed] [Google Scholar]
  5. Burge P. S. EUROSCOP, ISOLDE and the Copenhagen city lung study. Thorax. 1999 Apr;54(4):287–288. doi: 10.1136/thx.54.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cabello H., Torres A., Celis R., El-Ebiary M., Puig de la Bellacasa J., Xaubet A., González J., Agustí C., Soler N. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J. 1997 May;10(5):1137–1144. doi: 10.1183/09031936.97.10051137. [DOI] [PubMed] [Google Scholar]
  7. Celli B. R. Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Yes. Am J Respir Crit Care Med. 1997 Mar;155(3):781–783. doi: 10.1164/ajrccm.155.3.9117007. [DOI] [PubMed] [Google Scholar]
  8. Collet J. P., Shapiro P., Ernst P., Renzi T., Ducruet T., Robinson A. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med. 1997 Dec;156(6):1719–1724. doi: 10.1164/ajrccm.156.6.9612096. [DOI] [PubMed] [Google Scholar]
  9. Connors A. F., Jr, Dawson N. V., Thomas C., Harrell F. E., Jr, Desbiens N., Fulkerson W. J., Kussin P., Bellamy P., Goldman L., Knaus W. A. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959–967. doi: 10.1164/ajrccm.154.4.8887592. [DOI] [PubMed] [Google Scholar]
  10. Coultas D. B. Health effects of passive smoking. 8. Passive smoking and risk of adult asthma and COPD: an update. Thorax. 1998 May;53(5):381–387. doi: 10.1136/thx.53.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elosua R., Marrugat J., Molina L., Pons S., Pujol E. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. Am J Epidemiol. 1994 Jun 15;139(12):1197–1209. doi: 10.1093/oxfordjournals.aje.a116966. [DOI] [PubMed] [Google Scholar]
  12. Fabbri L., Beghé B., Caramori G., Papi A., Saetta M. Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax. 1998 Sep;53(9):803–808. doi: 10.1136/thx.53.9.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garcia-Aymerich J., Barreiro E., Farrero E., Marrades R. M., Morera J., Antó J. M. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J. 2000 Dec;16(6):1037–1042. doi: 10.1034/j.1399-3003.2000.16f03.x. [DOI] [PubMed] [Google Scholar]
  14. Garcia-Aymerich J., Monsó E., Marrades R. M., Escarrabill J., Félez M. A., Sunyer J., Antó J. M., EFRAM Investigators Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1002–1007. doi: 10.1164/ajrccm.164.6.2006012. [DOI] [PubMed] [Google Scholar]
  15. Kessler R., Faller M., Fourgaut G., Mennecier B., Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Jan;159(1):158–164. doi: 10.1164/ajrccm.159.1.9803117. [DOI] [PubMed] [Google Scholar]
  16. Madison J. M., Irwin R. S. Chronic obstructive pulmonary disease. Lancet. 1998 Aug 8;352(9126):467–473. doi: 10.1016/S0140-6736(97)11081-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Maltais F., LeBlanc P., Simard C., Jobin J., Bérubé C., Bruneau J., Carrier L., Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):442–447. doi: 10.1164/ajrccm.154.2.8756820. [DOI] [PubMed] [Google Scholar]
  18. Murray C. J., Lopez A. D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2. [DOI] [PubMed] [Google Scholar]
  19. Murray P. R., Washington J. A. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc. 1975 Jun;50(6):339–344. [PubMed] [Google Scholar]
  20. Nichol K. L., Baken L., Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999 Mar 2;130(5):397–403. doi: 10.7326/0003-4819-130-5-199903020-00003. [DOI] [PubMed] [Google Scholar]
  21. Osman I. M., Godden D. J., Friend J. A., Legge J. S., Douglas J. G. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997 Jan;52(1):67–71. doi: 10.1136/thx.52.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Salas M., Hofman A., Stricker B. H. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol. 1999 Jun 1;149(11):981–983. doi: 10.1093/oxfordjournals.aje.a009758. [DOI] [PubMed] [Google Scholar]
  24. Seemungal T. A., Donaldson G. C., Bhowmik A., Jeffries D. J., Wedzicha J. A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 May;161(5):1608–1613. doi: 10.1164/ajrccm.161.5.9908022. [DOI] [PubMed] [Google Scholar]
  25. Seemungal T. A., Donaldson G. C., Paul E. A., Bestall J. C., Jeffries D. J., Wedzicha J. A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418–1422. doi: 10.1164/ajrccm.157.5.9709032. [DOI] [PubMed] [Google Scholar]
  26. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  27. Sousa Ana R., Parikh Abhi, Scadding Glenis, Corrigan Christopher J., Lee Tak H. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002 Nov 7;347(19):1493–1499. doi: 10.1056/NEJMoa013508. [DOI] [PubMed] [Google Scholar]
  28. Stürmer T., Glynn R. J., Kliebsch U., Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol. 2000 Jan;53(1):57–64. doi: 10.1016/s0895-4356(99)00137-7. [DOI] [PubMed] [Google Scholar]
  29. Sunyer J., Antó J. M., McFarlane D., Domingo A., Tobías A., Barceló M. A., Múnoz A. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Sep;158(3):851–856. doi: 10.1164/ajrccm.158.3.9801093. [DOI] [PubMed] [Google Scholar]
  30. Taylor H. L., Jacobs D. R., Jr, Schucker B., Knudsen J., Leon A. S., Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31(12):741–755. doi: 10.1016/0021-9681(78)90058-9. [DOI] [PubMed] [Google Scholar]
  31. Wegner R. E., Jörres R. A., Kirsten D. K., Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J. 1994 Apr;7(4):725–729. doi: 10.1183/09031936.94.07040725. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES